Rani Therapeutics Holdings (RANI) Change in Account Payables (2020 - 2026)
Rani Therapeutics Holdings' Change in Account Payables history spans 7 years, with the latest figure at $549000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 240.99% to $549000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$662000.0, a 192.72% decrease, with the full-year FY2025 number at -$1.0 million, down 247.68% from a year prior.
- Change in Account Payables came in at $549000.0 for Q1 2026, up from -$2.2 million in the prior quarter.
- The five-year high for Change in Account Payables was $1.1 million in Q3 2024, with the low at -$2.2 million in Q4 2025.
- Historically, Change in Account Payables has averaged -$13058.8 across 5 years, with a median of $131000.0 in 2022.
- Biggest five-year swings in Change in Account Payables: surged 362.5% in 2022 and later crashed 942.51% in 2025.
- Year by year, Change in Account Payables stood at -$214000.0 in 2022, then tumbled by 209.81% to -$663000.0 in 2023, then skyrocketed by 68.78% to -$207000.0 in 2024, then tumbled by 942.51% to -$2.2 million in 2025, then skyrocketed by 125.44% to $549000.0 in 2026.
- Business Quant data shows Change in Account Payables for RANI at $549000.0 in Q1 2026, -$2.2 million in Q4 2025, and $669000.0 in Q3 2025.